[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fbF0zZ5vOYKSlZAmzITmhmzN7Bo2C2NPzgE7K4i3m92A":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":33,"type":34},[],"2025-06-20 19:54:38",205420587,[8,9,10,11,12],"系统评价","Meta分析","临床流行病学","查找证据的药学","最佳证据、药学实践经验和实际需求的有机结合",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},120,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","f717516301a645c1a8db86193076d757","课本附加","循证药学就是( )",[22,35,41,50,60,67,77,87,97,107],{"answer":23,"createTime":24,"id":25,"options":26,"question":32,"source":33,"type":34},[],"2025-06-20 19:54:37",205420556,[27,28,29,30,31],"药物预防、治疗疾病的理论和方法","药物与生物体之间相互作用机制和规律","药物和人体之间相互作用及其规律","人体对药物的处置过程","药物对人体的治疗作用","临床药理学是研究( )","v1",0,{"answer":36,"createTime":24,"id":37,"options":38,"question":40,"source":33,"type":34},[],205420557,[29,39,30,27,28],"药物在人体内效应部位的浓度与药效之间的关系","药物治疗学是研究( )",{"answer":42,"createTime":24,"id":43,"options":44,"question":49,"source":33,"type":34},[],205420558,[45,39,46,47,48],"遗传因素对于药效学、药动学及毒性的影响","以群体健康人和患者为对象,主要任务是评价药物","以患者为对象,研究药物及其剂型与病体相互作用和应用规律","药物和人体之间相互作用及其规律的学科","临床药学是研究( )",{"answer":51,"createTime":24,"id":52,"options":53,"question":59,"source":33,"type":34},[],205420559,[54,55,56,57,58],"以动物为实验对象,研究新药的药效学、药动学及毒性","研究药物剂型因素、生物因素与药效之间的关系","在患者或健康志愿者中进行的试验药品的系统性研究","已批准上市的药品,对其安全有效性及费用等做出科学评估","以人为研究对象,研究新药的药效学、药动学及毒性","市场药物的再评价是指( )",{"answer":61,"createTime":24,"id":62,"options":63,"question":66,"source":33,"type":34},[],205420560,[64,65],"临床护师 D.临床药理工作者","临床药师 E.临床药学工作者","药学服务(药学监护)主要由( )负责完成",{"answer":68,"createTime":24,"id":69,"options":70,"question":76,"source":33,"type":34},[],205420561,[71,72,73,74,75],"Emax不变,曲线右移","Emax下降,曲线下移","Emax不变,曲线左移","Emax下降,曲线上移","Emax不变,曲线下移","应用竞争性拮抗药后,受体激动药的量效曲线变化表现为()",{"answer":78,"createTime":24,"id":79,"options":80,"question":86,"source":33,"type":34},[],205420562,[81,82,83,84,85],"目标浓度","治疗指数","稳态血药浓度","有效血药浓度范围","血药浓度治疗区间","最低有效浓度和最低毒副反应浓度之间的血药浓度范围称为()",{"answer":88,"createTime":24,"id":89,"options":90,"question":96,"source":33,"type":34},[],205420563,[91,92,93,94,95],"变态反应","遗传因素决定的不良反应","获得性异常","先天性敏感性增高引起的其他反应","后遗效应","患者由于注射青霉素而发生过敏性休克的原因是()",{"answer":98,"createTime":24,"id":99,"options":100,"question":106,"source":33,"type":34},[],205420564,[101,102,103,104,105],"新药的毒副反应","新药的疗效","新药的不良反应处理方法","新药体内过程及给药方案","比较新药与已知药的疗效","药物代谢动力学研究的内容是()",{"answer":108,"createTime":24,"id":109,"options":110,"question":116,"source":33,"type":34},[],205420565,[111,112,113,114,115],"药物所处环境的 pH","患者的精神状态","肝、肾功能状态","药物血浆蛋白率高低","肾小球滤过率高低","影响药物吸收的因素是()"]